Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial
- PMID: 32699621
- PMCID: PMC7367106
- DOI: 10.1093/ckj/sfz068
Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial
Abstract
Background: Acute kidney injury (AKI) is frequent in patients resuscitated from cardiac arrest (CA) and may worsen outcome. Experimental data suggest a renoprotective effect by treating these patients with a high dose of erythropoietin (Epo) analogues. We aimed to evaluate the efficacy of epoetin alpha treatment on renal outcome after CA.
Methods: We did a post hoc analysis of the Epo-ACR-02 trial, which randomized patients with a persistent coma after a witnessed out-of-hospital CA. Only patients admitted in one intensive care unit were analysed. In the intervention group, patients received five intravenous injections of Epo spaced 12 h apart during the first 48 h, started as soon as possible after resuscitation. In the control group, patients received standard care without Epo. The main endpoint was the proportion of patients with persistent AKI defined by Kidney Disease: Improving Global Outcomes criteria at Day 2. Secondary endpoints included the occurrence of AKI through Day 7, estimated glomerular filtration rate (eGFR) at Day 28, haematological indices and adverse events.
Results: A total of 162 patients were included in the primary analysis (74 in the Epo group, 88 in the control group). Baseline characteristics were similar in the two groups. At Day 2, 52.8% of the patients (38/72) in the intervention group had an AKI, as compared with 54.4% of the patients (46/83) in the control group (P = 0.74). There was no significant difference between the two groups regarding the proportion of patients with AKI through Day 7. Among patients with persistent AKI at Day 2, 33% (4/12) in the intervention group had an eGFR <75 mL/min/1.73 m2 compared with 25% (3/12) in the control group at Day 28 (P = 0.99). We found no significant differences in haematological indices or adverse events.
Conclusion: After CA, early administration of Epo did not confer any renal protective effect as compared with standard therapy.
Keywords: cardiopulmonary resuscitation; renal function; reperfusion injury.
© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.
References
-
- Neumar RW, Nolan JP, Adrie C. et al. Post cardiac arrest syndrome: epidemiology, pathophysiology, treatment and prognostication. A consensus statement from the international liaison committee on resuscitation. Circulation 2008; 118: 2452–2483 - PubMed
-
- Geri G, Guillemet L, Dumas F. et al. Acute kidney injury after out-of-hospital cardiac arrest: risk factors and prognosis in a large cohort. Intensive Care Med 2015; 41: 1273–1280 - PubMed
-
- Yanta J, Guyette FX, Doshi AA. et al. Renal dysfunction is common following resuscitation from out-of-hospital cardiac arrest. Resuscitation 2013; 84: 1371–1374 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
